Trial intelligence / Profile preview

Albumin vs Crystalloid for Alveolar Fluid Clearance in ARDS

NCT01763853Phase 4Unknown

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Dec 2012
Primary completion
Apr 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of albumin (human) in acute respiratory distress syndrome (ARDS), hypovolemia, pulmonary edema, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.

02

Drugs

albumin (human)
03

Conditions

acute respiratory distress syndrome (ARDS)hypovolemiapulmonary edema

Beyond the preview

Go deeper on NCT01763853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01763853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call